Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

2.

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.

D'Souza S, Rosseels V, Romano M, Tanghe A, Denis O, Jurion F, Castiglione N, Vanonckelen A, Palfliet K, Huygen K.

Infect Immun. 2003 Jan;71(1):483-93.

3.

Improved tuberculosis DNA vaccines by formulation in cationic lipids.

D'Souza S, Rosseels V, Denis O, Tanghe A, De Smet N, Jurion F, Palfliet K, Castiglioni N, Vanonckelen A, Wheeler C, Huygen K.

Infect Immun. 2002 Jul;70(7):3681-8.

4.

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K.

Int J Cancer. 2000 Sep 15;87(6):844-52.

5.

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

Zlotta AR, van Vooren JP, Huygen K, Drowart A, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Simon J, Schulman CC.

Eur Urol. 2000 Apr;37(4):470-7.

PMID:
10765079
6.

Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy.

Zlotta AR, Drowart A, Van Vooren JP, Shekarsarai H, De Cock M, Pirson M, Palfliet K, Jurion F, Simon J, Schulman CC, Huygen K.

J Urol. 1998 Jun;159(6):1885-91.

PMID:
9598481
7.

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.

Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg TP, Vanonckelen A, Ooms J, Saman E, Ulmer JB, Content J, Huygen K.

Infect Immun. 1998 Apr;66(4):1527-33.

8.

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.

Lozes E, Denis O, Drowart A, Jurion F, Palfliet K, Vanonckelen A, De Bruyn J, De Cock M, Van Vooren JP, Huygen K.

Scand J Immunol. 1997 Jul;46(1):16-26.

9.

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.

Zlotta AR, Drowart A, Huygen K, De Bruyn J, Shekarsarai H, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Mascart F, Simon J, Schulman CC, Van Vooren JP.

Clin Exp Immunol. 1997 Jul;109(1):157-65.

10.

[The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].

Shekarsarai H, Zlotta AR, Drowart A, Van Vooren JP, De Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.

Acta Urol Belg. 1997 Mar;65(1):1-4. French.

PMID:
9245197
11.

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.

Zlotta AR, Drowart A, Van Vooren JP, de Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.

J Urol. 1997 Feb;157(2):492-8.

PMID:
8996341
12.

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG.

Huygen K, Lozes E, Gilles B, Drowart A, Palfliet K, Jurion F, Roland I, Art M, Dufaux M, Nyabenda J, et al.

Infect Immun. 1994 Feb;62(2):363-70.

13.

Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG.

Huygen K, Palfliet K, Jurion F, Lenoir C, van Vooren JP.

Clin Exp Immunol. 1990 Nov;82(2):369-72.

14.

H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin.

Huygen K, Palfliet K, Jurion F, Hilgers J, ten Berg R, Van Vooren JP, De Bruyn J.

Infect Immun. 1988 Dec;56(12):3196-200.

15.

Influence of in vivo immunosuppressive drugs on production of lymphokines.

Dupont E, Huygen K, Schandené L, Vandercruys M, Palfliet K, Wybran J.

Transplantation. 1985 Feb;39(2):143-7.

PMID:
3918367
16.

Depressed natural killer function in transplant recipients: an analysis.

Dupont E, Huygen K, Schandene L, Vandercruys M, Palfliet K, Wybran J.

Transplant Proc. 1984 Dec;16(6):1506-8. No abstract available.

PMID:
6438846
19.

In vitro production of gamma interferon is dependent on the mouse genotype.

Huygen K, Palfliet K.

J Interferon Res. 1983;3(1):129-37.

PMID:
6221053
20.

Supplemental Content

Loading ...
Support Center